Yuhan Corporation
000100
株式のランク
#3832
Yuhan Corporation, a prominent South Korean pharmaceutical firm established in... Yuhan Corporation, a prominent South Korean pharmaceutical firm established in 1926 and headquartered in Seoul, specializes in the research, development, and manufacture of active pharmaceutical ingredients (APIs) and intermediates for both domestic and international markets. Its extensive product portfolio encompasses a wide array of prescription pharmaceuticals (ETC), addressing therapeutic areas such as cardiovascular, alimentary, genito-urinary, metabolic, respiratory, allergy, and neurological systems, alongside anti-infectives, anti-cancer treatments, and hormonal therapies. Notable offerings include Revanex, an acid pump antagonist designed for treating peptic ulcers and gastritis-related mucosal injury. Beyond prescription drugs, Yuhan Corporation provides a diverse range of over-the-counter (OTC) medications, including vitamins, mineral supplements, hepatopathy treatments, tonics, and drugs for respiratory, alimentary, dermatological, and pain relief applications. The company also extends its reach into consumer health and household goods, producing items like bleaches, detergents, pesticides, and oral care products. Further diversifying its operations, Yuhan is involved in the dental sector, supplying implants, equipment, consumables, and dental care solutions, and manufactures veterinary medical supplies for livestock, aquatic species, and companion animals. Additionally, it offers contract manufacturing services to other businesses.
株価
$63.22
時価総額
$4.27B
変化（1日）
-3.12%
変化（1年）
-23.57%
国
KR
取引 Yuhan Corporation (000100)
カテゴリー
Healthcare
Yuhan Corporation（000100）の発行済株式数
June 2026 時点の発行済株式数 85.45M
Yuhan Corporation の最新の財務報告および株価によると、現在の発行済株式数は 85.45M です。December 2024 の終わりには、同社は 74.96M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Yuhan Corporation（000100）の発行済株式数の履歴（2007 ～ 2026）
各年末時点の発行済株式数
| 年 | 発行済株式数 | 変化 |
|---|---|---|
| 2026 (TTM) | 85.45M | 5.29% |
| 2025 | 81.15M | 8.26% |
| 2024 | 74.96M | -0.05% |
| 2023 | 75.00M | -0.25% |
| 2022 | 75.19M | -0.54% |
| 2021 | 75.59M | -0.19% |
| 2020 | 75.74M | 4.86% |
| 2019 | 72.23M | 4.54% |
| 2018 | 69.09M | 1.05% |
| 2017 | 68.38M | -0.62% |
| 2016 | 68.80M | -4.83% |
| 2015 | 72.29M | -0.71% |
| 2014 | 72.81M | -1.12% |
| 2013 | 73.63M | -0.02% |
| 2012 | 73.65M | -1.42% |
| 2011 | 74.71M | -4.01% |
| 2010 | 77.83M | -1.28% |
| 2009 | 78.84M | 2.50% |
| 2008 | 76.91M | -2.25% |
| 2007 | 78.68M | 0.00% |
類似企業や競合他社の発行済株式数
| 企業 | 発行済株式数 | 差 | 国 |
|---|---|---|---|
| 434.78M | 408.84% |
DE
|
|
| 434.78M | 408.84% |
DE
|
|
| 1.56B | 1,728.75% |
JP
|
|
| 233.66M | 173.46% |
CH
|
|
| 2.40B | 2,708.05% |
IN
|
